Tian et al., 2014 - Google Patents
Effects of sublingual immunotherapy for Dermatophagoides farinae on Th17 cells and CD4+ CD25+ regulatory T cells in peripheral blood of children with allergic …Tian et al., 2014
- Document ID
- 15101753084314350995
- Author
- Tian M
- Wang Y
- Lu Y
- Jiang Y
- Zhao D
- Publication year
- Publication venue
- International forum of allergy & rhinology
External Links
Snippet
Background Sublingual immunotherapy is becoming a more common treatment for allergic diseases, particularly in pediatric clinics. This type of treatment is highly effective for Dermatophagoides farinae allergy, but the mechanisms resulting in immune tolerance have …
- 241000238713 Dermatophagoides farinae 0 title abstract description 33
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tian et al. | Effects of sublingual immunotherapy for Dermatophagoides farinae on Th17 cells and CD4+ CD25+ regulatory T cells in peripheral blood of children with allergic asthma | |
| Lou et al. | Responses of CD4+ CD25+ Foxp3+ and IL‐10‐secreting type IT regulatory cells to cluster‐specific immunotherapy for allergic rhinitis in children | |
| Zhang et al. | Advances and highlights in allergic rhinitis | |
| Abdel‐Gadir et al. | Oral immunotherapy with omalizumab reverses the Th2 cell‐like programme of regulatory T cells and restores their function | |
| Smith et al. | Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia | |
| Park et al. | Comparative analysis of the microbiome across the gut–skin axis in atopic dermatitis | |
| Oren et al. | Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response | |
| Gauvreau et al. | OX 40L blockade and allergen‐induced airway responses in subjects with mild asthma | |
| Wong et al. | The role of macrolides in asthma: current evidence and future directions | |
| Wang et al. | Food allergy | |
| Vultaggio et al. | Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab | |
| Savolainen et al. | Sublingual immunotherapy in children modulates allergen‐induced in vitro expression of cytokine mRNA in PBMC | |
| Alexander et al. | The effect of Fel d 1‐derived T‐cell peptides on upper and lower airway outcome measurements in cat‐allergic subjects | |
| Camporota et al. | The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma | |
| Schaub et al. | Impairment of T helper and T regulatory cell responses at birth | |
| Yao et al. | CD23 expression on switched memory B cells bridges T‐B cell interaction in allergic rhinitis | |
| Di Pierro et al. | Use of a standardized extract from Echinacea angustifolia (Polinacea [R]) for the prevention of respiratory tract infections | |
| Clutterbuck et al. | Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine | |
| Chirkova et al. | Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine | |
| Cianci et al. | The interplay between immunosenescence and microbiota in the efficacy of vaccines | |
| McManus et al. | Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia | |
| Burns et al. | Antibody response to vaccination as a marker of in vivo immune function in psychophysiological research | |
| Farmaki et al. | Immunogenicity and immunological memory induced by the 13-valent pneumococcal conjugate followed by the 23-valent polysaccharide vaccine in HIV-infected adults | |
| Boyle et al. | Effects of Lactobacillus GG treatment during pregnancy on the development of fetal antigen‐specific immune responses | |
| Zhang et al. | Effects of macrolides on airway microbiome and cytokine of children with bronchiolitis: A systematic review and meta‐analysis of randomized controlled trials |